🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Hospital do Coracao clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Brazil register with Hospital do Coracao as lead sponsor. Synced 28 Sep 2026
12Current trials
7Recruiting now
2Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Hospital do Coracao is the lead sponsor of 12 current clinical trials in our Brazil register. 7 are recruiting patients now. The most common phase is Phase 3. The drugs named most often in its trials are Colchicine and Vasopressin. The most-studied condition is Congenital Heart Disease (CHD).

ClinicalTrials.gov trials by status

  • Recruiting758%
  • Not yet open217%
  • Active, closed325%

Trials by phase

  • Phase 3433%
  • Not applicable325%
  • Observational325%
  • Phase 218%
  • Phase 1/218%
01

Clinical trials sponsored by Hospital do Coracao

12 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Characterization of Weaning Practices in ICUs of Global South Countries
NCT07337408 · ClinicalTrials.gov ↗ · Weaning From Mechanical Ventilation, Weaning Failure, Weaning From Mechanical Ventilation, Extubation
Observational Recruiting 2026-05 Brazil
Use of Vasopressin in Patients at High Risk of Acute Kidney Injury Admitted to the ICU
NCT06547892 · ClinicalTrials.gov ↗ · Critical Illness
Phase 2 Recruiting 2025-04 Brazil
Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease
NCT06930885 · ClinicalTrials.gov ↗ · Atherothrombotic Diseases, Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3 Recruiting 2025-06 Brazil
CRYoablation for Small Tumors As Local Treatment - SIX Trial
NCT06839001 · ClinicalTrials.gov ↗ · Breast Cancer, Breast Neoplasm
Phase 3 Recruiting 2025-03 Brazil
Adjuvant Chemotherapy in cfHPV-DNA Plasma Positive Patients: A Biomarker In Locally Advanced Cervical Cancer
NCT05764044 · ClinicalTrials.gov ↗ · Cervical Cancer, Cervix Cancer, Cervix Neoplasm
Phase 3 Recruiting 2024-03 Brazil
National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter Registry
NCT06546137 · ClinicalTrials.gov ↗ · Cardiomyopathy, Hypertrophic, Cardiomyopathy, Dilated, Cardiomyopathy Restrictive
Observational Recruiting 2025-04 Brazil
Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent Sepsis
NCT06464510 · ClinicalTrials.gov ↗ · Septic Shock
Phase 3 Recruiting 2024-11 Brazil
Low Dose Radiotherapy for Heart Failure
NCT07037524 · ClinicalTrials.gov ↗ · Heart Failure - NYHA II - IV
Phase 1/2 Not yet open 2025-07 Brazil
Oral Care Layered Enhancement for Improved Oral Hygiene in Intensive Care Units
NCT07129733 · ClinicalTrials.gov ↗ · Mechanical Ventilation, Infection Prevention, Oral Care
Not applicable Not yet open 2025-09 Brazil
Physical Rehabilitation in Patients With Complex Congenital Heart Disease
NCT07089264 · ClinicalTrials.gov ↗ · Congenital Heart Disease (CHD)
Not applicable Active, closed 2019-09 Brazil
An Adapted Brazilian Cardioprotective Diet, Phytosterols and Krill Oil in Familial Hypercholesterolemia (DICA-FH)
NCT06331195 · ClinicalTrials.gov ↗ · Familial Hypercholesterolemia
Not applicable Active, closed 2024-10 Brazil
LIQUID BIOPSY FOCUSING ON CIRCULATING TUMOR CELLS AND CIRCULATING TUMOR DNA AS PRECISION MEDICINE IN GASTROINTESTINAL TUMORS
NCT06940778 · ClinicalTrials.gov ↗ · Cancer of Rectum, Cancer of Pancreas, Cancer of Stomach
Observational Active, closed 2025-01 Brazil

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Hospital do Coracao trials

2 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Hospital do Coracao trials

26 conditions
Congenital Heart Disease (CHD)1Weaning From Mechanical Ventilation1Weaning Failure1Weaning From Mechanical Ventilation, Extubation1Critical Illness1Heart Failure - NYHA II - IV1Mechanical Ventilation1Infection Prevention1Oral Care1Oral Hygiene, Oral Health1Atherothrombotic Diseases1Atherosclerotic Cardiovascular Disease (ASCVD)1Familial Hypercholesterolemia1Breast Cancer1Breast Neoplasm1Cancer of Rectum1Cancer of Pancreas1Cancer of Stomach1Cervical Cancer1Cervix Cancer1Cervix Neoplasm1Cardiomyopathy, Hypertrophic1Cardiomyopathy, Dilated1Cardiomyopathy Restrictive1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in Brazil127

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Congenital Heart Disease (CHD)

SponsorTrials
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine3
Yan Fuxia2

Sponsors with the most current trials registered for this condition.

06

Questions about Hospital do Coracao trials

How many clinical trials does Hospital do Coracao sponsor?

Hospital do Coracao is the lead sponsor of 12 current trials on ClinicalTrials.gov in our Brazil register, as of the registry sync on 28 September 2026. Completed and withdrawn studies are not counted.

Are Hospital do Coracao trials recruiting?

Yes. 7 of its 12 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Hospital do Coracao testing?

Its current trials name 2 drugs and biologicals as interventions. The most frequent are Colchicine (1) and Vasopressin (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 28 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.